Saturday, January 12, 2019 9:32:17 AM
“ According to its data, it looks like MedMen Enterprises Inc. (MMNFF) is poised to be the big winner as a result of its acquisition of PharmaCann, which had the highest number of permits awarded in the state. MedMen acquired PharmaCann for $682 million in an all-stock deal back in October. The transaction not only doubled the reach for MedMen, but expanded its presence in New York.
MedMen had acquired New York's struggling Bloomfield Industries at the beginning of 2018. The company had been unable to pay vendors and was looking for new investors. Bloomfield was one of the original five licensees in New York.
MedMen made a big splash when it opened its 5th Avenue dispensary. At the time plenty of cannabis industry insiders questioned the logic of paying such a high rent for the high visibility of a Manhattan address in a program with so few patients. They wondered how long it would take for a restrictive state such as New York to change its outlook on adult use cannabis. Apparently. the answer was not very long.”
https://realmoney.thestreet.com/investing/cannabis/if-new-york-legalizes-recreational-marijuana-here-is-who-could-cash-in-14815874?_ga=2.217935248.700979300.1547302867-1801583889.1518878411
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM